REHAN AZIZ: Open Payments
NPI 1457391310 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 7 payments from 5 companies in 2025. Trend: 2023 $30 · 2024 $51 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $135 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Lundbeck LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: KISUNLA, INGREZZA, AMYVID, REXULTI, COBENFY, INVEGA SUSTENNA.
Industry payments across NJ — which companies pay providers there.
